Michael Cruse
Senior VP, Corporate Operation, OnKure Therapeutics, Inc.
Companies
- OnKure Therapeutics, Inc.Chief operating officer Mar 4, 2022 to Dec 13, 20221
- OnKure Therapeutics, Inc.Senior VP, Corporate Operation Apr 8, 2021 to Dec 14, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OnKure Therapeutics, Inc. OKUR49,455 shares3$105.3K at $2.13Dec 13, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2022Bought 7,500 shares at $3.39 of OnKure Therapeutics, Inc.4
- Aug 31, 2022Bought 3,212 shares at $3.21 of OnKure Therapeutics, Inc.5
- Aug 30, 2022Bought 1,845 shares at $3.19 of OnKure Therapeutics, Inc.5
- Aug 30, 2022Bought 975 shares at $3.16 of OnKure Therapeutics, Inc.5
- Aug 29, 2022Bought 1,140 shares at $3.24 of OnKure Therapeutics, Inc.5
- Aug 29, 2022Bought 83 shares at $3.24 of OnKure Therapeutics, Inc.5
- Dec 10, 2021Granted 25,000 shares of OnKure Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Sep 2, 2022
- 5SEC EDGARForm 4 filed Aug 31, 2022
- 6SEC EDGARForm 4 filed Dec 14, 2021